Skip to main content
Premium Trial:

Request an Annual Quote

Wellcome Trust Awards $2.7M for Alzheimer's Genome-Wide Association Study

NEW YORK (GenomeWeb News) – The UK’s Wellcome Trust said this week that it has awarded £1.3 million ($2.7 million) to support a large genome-wide association study with the goal of understanding the genetic basis of late-onset Alzheimer's disease.
 
Cardiff University will lead the project, which will analyze DNA samples from 14,000 people -- 6,000 with late-onset Alzheimer's disease and 8,000 controls from the UK and US.
 
The researchers hope to identify common genetic variations that either increase the risk of late-onset Alzheimer’s or protect patients from developing the disease.
 
Julie Williams, a professor of neuropsychological genetics at Cardiff University and the principal investigator on the project, said in a statement that it is the “largest genetic study ever to look at Alzheimer's.”
 

Panos Deloukas’ group at the Wellcome Trust Sanger Institute will perform the genotyping for the study with Illumina’s HumanHap550 Genotyping BeadChips.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.